Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Opioides
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opioid Receptor, molecular model Stock Photo - Alamy
Human RANkL CLIA Kit | Receptor Activator of Nuclear Factor Kappa B Ligand CLIA | stjohnslabs
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion - ScienceDirect
Pathways and Receptors – Opioid Peptides
Opioid Receptor | kappa, mu Opioid Receptor
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)